Skip to main content
. 2002 Feb;87(2):177–184. doi: 10.1136/heart.87.2.177

Table 8.

Management of opportunistic infections after cardiac transplantation

Organism Test Treatment
Cytomegalovirus IE-Gene, PCR, IgM Gancyclovir, if severe additional CMV antibodies
Herpes simplex virus IgM Aciclovir
Varicella-zoster virus IgM Aciclovir
Hepatitis B virus IgM Lamivudine
Legionella species Urine antigen, x ray Erythromycin
Mycobacterium tuberculosis Ziehl-Neelson Rifampicin, isoniazid, myambutol
Nocardia asteroides Brain CT Sulfamethoxazole/trimethoprim
Pneumocystis carinii x ray Sulfamethoxazole/trimethoprim
Toxoplasma gondii X ray, IFT, CFT, IgA, IgM Pyrimethamine + sulfadiazine, folic acid
Candida albicans Direct Fluconazole, itraconazole
Aspergillus fumigatus X ray Itraconazole, amphotericin B, flucytosine
Cryptococcus neoformans Brain CT Itraconazole, amphotericin B, flucytosine, or fluconazole
Listeria monocytogenes CNS: ampicillin + gentamycin

CMV, cytomegalovirus; CT computed tomography; IFT immunofluoresence test; CFT, complement fixation test.